🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Measles is a highly contagious disease which can result in severe complicat...
Status
Completed
Location
King's College London
Start Date
2024-09-12
Trial ID
NCT06456788
Treatments Being Tested
This study is an open-label, single-arm Phase Ib/II clinical trial designed...
Status
Unknown
Location
Hubei Cancer Hospital
Start Date
2023-12-12
Trial ID
NCT06224842
This study is researching an experimental drug called fianlimab (also calle...
Status
Recruiting
Location
University of California Los Angeles
Start Date
2026-04-14
Trial ID
NCT06769698
Treatments Being Tested
This study is a multicenter, open-label study of polatuzumab vedotin admini...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-10-15
Trial ID
NCT02257567
The Bacille Calmette-Guérin (BCG) vaccine is the only vaccine licenced to p...
Status
Completed
Location
University of Oxford, Oxford Vaccine Group
Start Date
2014-06-20
Trial ID
NCT02002156
The purpose of this study is to evaluate the immune response and safety of ...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-05-15
Trial ID
NCT06806137
The objective of this trial was to explore the dose-response relation of su...
Status
Completed
Location
Multiple Locations
Start Date
2004-03-04
Trial ID
NCT00535743
Treatments Being Tested
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
1998-06-02
Trial ID
NCT00005792
Treatments Being Tested
The purpose of this study is to assess the consistency of immune response t...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-01-10
Trial ID
NCT06740630